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http://dx.doi.org/10.1016/j.kjms.201Abstract The aim of the present study is to describe recent issues with Yusho disease in
Japan, describe the state of dioxin accumulation and the intake of dioxin via food in Japan,
and introduce the Japan Environment and Children’s Study. Yusho disease manifested in
western Japan in 1968. The causes of Yusho are believed to be dioxin-related compounds,
mainly polychlorinated biphenyls (PCBs) and polychlorinated dibenzofurans (PCDFs), via the
ingestion of rice oil produced in February 1968. As of March 31, 2011, there were 1961 regis-
tered Yusho cases, but of these 539 are deceased. A retrospective cohort study on registered
Yusho cases reported that the standardized mortality ratios (SMRs) for the major causes of
death were not significantly elevated, with the exception of all-cancer (SMRZ 1.26; 95% confi-
dence interval [CI]: 1.03e1.53) and lung cancer mortality (SMRZ 1.56; 95% CI: 1.03e2.27) in
males. The results of the Yusho mortality study show that the SMR for liver cancer in males
tends to decrease over time. In 2011, the Ministry of the Environment of Japan reported that
the average concentration of dioxins in the blood (2002e2010) of the Japanese people was 19
pg-TEQ/g-fat, demonstrating a range of 0.10e130 pg-TEQ/g-fat, and that the average dioxin
intake from food (2002e2010) was 0.82 pg-TEQ/kg-body weight/day, demonstrating a range
of 0.031e6.2 pg-TEQ/kg-body weight/day according to 2006 WHO TEFs. The Japan Environ-
ment and Children’s Study Project was launched in 2011 and is supported by the Ministry of
the Environment of Japan. In this project, 100,000 mother and child pairs will be recruited
over 3 years from designated study areas. Follow-up examinations will be carried out from
pregnancy until the children are 13 years of age (a so-called birth-cohort study). This project
will be implemented by the National Center at the National Institute for Environmental Studies
and is supported by the Medical Support Center at the National Center for Child Health and
Development. Field operations will be performed at 15 designated regional centers nation-
wide.
Copyright ª 2012, Elsevier Taiwan LLC. All rights reserved.uoka-City 813-8529, Japan.
jp.
vier Taiwan LLC. All rights reserved.
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The aim of the present study is to describe recent issues
with Yusho disease in Japan, describe the state of dioxin
accumulation and the intake of dioxin via food in Japan,
and introduce the Japan Environment and Children’s Study.Figure 1. Deodorization process for rice oil production.History of Yusho
A strange disease was first reported on October 10, 1968 in
western Japan, even though several patients with peculiar
symptoms had been recognized by alert clinicians several
months prior [1e3]. This strange diseasedcharacterized by
acne-like eruptions, pigmentation of the skin, and eye
dischargedwas named Yusho (“oil disease”) [2,4]. At that
time, no causal agents were suggested by either the health
authorities or other related professionals.
Later, the Yusho Study Group was established to clarify
the causal factors of Yusho and establish treatment
methods for these patients. The Yusho Study Group was
divided into three subgroups: clinical, chemical, and
epidemiologic [1,2].
Through intensive effort by the subgroup members (clini-
cians, epidemiologists, toxicologists, and chemists), the
causal agentwas determined to be polychlorinated biphenyls
(PCBs) within 1 month after the episode [1,2]. The epidemi-
ologic study subgroupconcludedthatYushowascausedby the
ingestion of a specific rice oil that was produced in early
February 1968 [2,3,5]. The rice oil was contaminated with
PCBs (commercial name: Kaneclor 400), which were used as
a trans-heater in the production of rice oil [2] (Fig. 1).
This conclusion, however, was questioned regarding the
following points [2,3]:
1) In 1971, Dr. Risebrough asked Prof. Kuratsune whether
Yusho was caused by PCBs alone or in combination with
polychlorinated dibenzofurans (PCDFs) or poly-
chlorinated dibenzodioxins (PCDDs).
2) No dermatological lesions similar to those observed in
human beings could be shown to be caused by pure
PCBs (Kanechlor 400) in animal experiments.
3) Yusho patients showed severe clinical symptoms even
though their blood PCB levels were rather low. In
addition, workers exposed to PCBs showed almost no
clinical symptoms even though their blood PCB levels
were rather high.
In the three year period from 1975e1977, a significant
amount of PCDF was detected in the toxic rice oil consumed
by Yusho patients, as well as in their tissues. A further
investigation revealed that the most important causal
agents for Yusho were PCDFs in combination with PCBs [2,3].
In 1990, the Japanese Government classified coplanar
PCBs, PCDFs, and PCDDs as a group of dioxin-like
compounds (Fig. 2).Figure 2. Related substance of PCB.The present situation of Yusho
As of March 31, 2011, there were 1961 registered Yusho
cases; of these, 539 are deceased.During the 40 years since the Yusho episode, the Yusho
Study Group has been working intensively to 1) clarify the
mechanisms of Yusho disease, 2) reduce the concentrations
of PCBs and PCDFs in the patients’ blood, 3) find treatment
methods for the symptoms reported by the patients, and 4)
set up diagnostic criteria based on the level of dioxins
measured in blood. These projects were supported by
a grant from the Ministry of Health, Labor, and Welfare of
Japan.
The findings of the Yusho Study Group were published in
the series of Yusho Study Reports [6], in addition to original
papers that were published in various scientific journals.
Details on the Yusho episode were described by Kuratsune
et al. [2] and in the supplement of the Journal of Derma-
tological Science [7]. Also, the Yusho Study Group published
two books in Japanese [8,9].
It should be noted that the diagnostic criteria for Yusho
have been modified according to the development of new
technology for analyzing dioxin levels in the blood. The
original diagnostic criteria for Yusho were proposed in 1968
based on the clinical symptoms and epidemiological
evidence. Later, the diagnostic criteria were modified
based on additional information obtained about PCB
patterns, PCQ levels, and PCDF levels in blood [2,7,10].
A Yusho outpatient clinic was opened at Kyushu Univer-
sity Hospital just after the initial episode, and an annual
health check-up system for Yusho patients was established
in 1969. In 1985, the data format was formulated to contain
systematic information about the Yusho patients. Details
regarding the information system used to collect data from
the annual health check-ups of Yusho patients was only
described in Japanese [9].
Legal cases against the Ministry of Health, Labor, and
Welfare of Japan, Kanemi Co., and Kanegafuchi Co., both
criminal and civil, were brought to trial and almost all of
them were finally settled.
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In order to determine if cancer mortality among Yusho
patients has increased or not, a retrospective cohort study
was conducted on the 1918 registered Yusho patients in
2007 [9]. By the end of 2007, of these 1918 registered Yusho
patients, 1383 alive patients (72.1%) and 502 deceased
patients (26.2%) were confirmed by the official residence
records. No information could be obtained about 33 cases
(1.7%). Record linkage was carried out using the govern-
ment death registry for the period from 1968e2007, and
a file on deceased Yusho patients stating the underlying
cause of death of each case was obtained. Standardized
mortality ratios (SMRs) were calculated using national
mortality data on age, sex, and year of death as reference
data. Although SMRs for liver cancer have been elevated for
the past 30 years, SMRs for liver cancer were slightly
elevated in both males (SMRZ 1.67; 95% confidence
interval [CI]: 0.99e2.63) and females (SMRZ 1.87; 95% CI:
0.81e3.69), but these results were not statistically signifi-
cant. Among males, the SMRs for all types of cancer
(SMRZ 1.26; 95% CI: 1.03e1.53) and lung cancer
(SMRZ 1.56; 95% CI: 1.03e2.27) were increased and
statistically significant, but not among females as pre-
sented in Table 1. The results of the mortality study on
Yusho patients show that the SMR for all liver cancers
among males had a tendency to decrease over time. This
interpretation, however, is unclear regarding the
carcinogenetic effects due to exposure to dioxin-like
compounds. The SMR for male lung cancer obtained here
might have been influenced by the smoking habits of theTable 1 Standardized mortality ratios (SMRs) according to
selected causes of death of Yusho patients.
SMRs in Males
Cause of death Obs Exp SMR 95% CI
All causes 295 268.7 1.10 (0.98e1.23)
All cancers 106 83.9 1.26 (1.03e1.53)
Stomach 21 19.2 1.09 (0.68e1.67)
Liver 18 10.8 1.67 (0.99e2.63)
Lung 27 17.3 1.56 (1.03e2.27)
HD 41 40.6 1.01 (0.73e1.37)
CVD 38 40.3 0.94 (0.67e1.30)
DM 1 3.3 0.31 (0.01e1.71)
SMRs in Females
Cause of death Obs Exp SMR 95% CI
All causes 207 202.9 1.02 (0.89e1.17)
All cancers 46 52.0 0.89 (0.65e1.18)
Stomach 4 10.3 0.39 (0.11e0.99)
Liver 8 4.3 1.87 (0.81e3.69)
Lung 5 5.8 0.86 (0.28e2.01)
HD 44 36.2 1.22 (0.88e1.63)
CVD 34 37.4 0.91 (0.63e1.27)
DM 2 3.0 0.66 (0.08e2.38)
Adapted from Reference 9.Yusho patients. However, the difference between in the
smoking rates of the Yusho patients (39.5%; derived from
the first fact-finding survey of Yusho patients in 2008) and
the general population (36.8%; derived from the National
Health and Nutrition Survey in 2008) are not especially
large. Therefore, the confounding effects of smoking on the
SMRs of male lung cancer would be insignificant; therefore,
detailed analysis of the effects of smoking as a confounding
factor is needed. The results shown above are almost
similar to the published data and are based on the data on
1664 registered Yusho patients as of 2007 [11].
Further issues to be clarified
Many studies have been carried out, and the results of
these studies have been published in scientific journals;
however, the following issues need to be clarified further.
First, the treatment of Yusho patients should be further
examined in order to mitigate the symptoms and signs that
patients currently face, such as reducing PCB and PCDF
levels in blood. Recently, clinical trials have been planned
and conducted in order to examine the effects of using
traditional medicine to treat Yusho patients.
Second, it is crucial to investigate the hazardous effects
of dioxin-related compounds in the second generation of
Yusho patients. Any information obtained regarding the
second generation would be calculable, although practical
difficulties obtaining, such information, are anticipated due
to ethical and privacy problems.
Third, it would be helpful to investigate past findings
(e.g., sex ratio at birth among babies born to Yusho
mothers, evaluation of the subjective symptoms reported
by Yusho patients) by analyzing the available data accu-
mulated by the Yusho Study Group, even though available
data are limited. One of the data sources would be the
following data set. In 2008, the Ministry of Health, Labor,
and Welfare of Japan carried out the first fact-finding
survey of all of the registered Yusho patients in order to
improve Yusho studies and provide better health care.
The targeted participants were all registered Yusho
patients as of March 2008. All eligible Yusho patients were
reached by local government authorities in order to
obtain consent to participate in this survey. The partici-
pants were asked to fill out a questionnaire (61 pages)
that was prepared by the planning committee and to
participate, with informed consent, in a medical exami-
nation conducted by the Yusho Study Group. The ques-
tionnaire included questions on personal and family
demographics, medical history, life style, health and
mental status, health status of their children and grand-
children, etc. [12].
Dioxin levels in Japan
The Office of Environmental Risk Assessment at the
Ministry of the Environment of Japan carried out a project
called “Survey on the Accumulation of Dioxins and Other
Chemical Compounds in Humans” from 2002e2010. The
objectives of this survey were to obtain an overview of the
accumulation of dioxins in the Japanese people and its
chronological changes in order to determine the intake
S52 T. Yoshimuralevel of dioxins via food and the primary source of dioxins
that enter the human body. A summary report appeared on
the homepage [13] of the Ministry of the Environment of
Japan. For the nationwide survey, the entire country was
divided into five survey regions, and one prefecture was
selected from each region for a particular year. Three
areas (urban, agricultural, and fishery) were selected
within each prefecture and designated as the survey
areas. Residents aged 15e70 years were recruited, blood
samples were collected, the level of dioxins was
measured, and a general health check-up and a dietary
survey was conducted (a duplicate-portion study for 3
days). A follow-up survey on the same residents was con-
ducted in order to evaluate chronological trends in dioxin
accumulation in the residents of designated cities and
towns from 2002e2010.
The results show that among 2264 people, the average
concentration of dioxins in the blood (over the 9-year survey
period) was 19 pg-TEQ/g-fat, demonstrating a range of
0.10e130 pg-TEQ/g-fat according to 2006 WHO TEFs [13].
These results are similar to those obtained by other repor-
ted surveys that have been conducted in Japan [13].
The results of the survey further revealed that blood
dioxin concentrations were significantly higher at fisheries
than urban or agricultural areas, and the blood concen-
trations in the latter two areas were similar. Some differ-
ences were suggested to be present among the five
surveyed regions.
Among 625 people, the average dioxin intake from food
(over the 9-year survey period) was 0.82 pg-TEQ/kg-body
weight/day, demonstrating a range of 0.031e6.2 pg-TEQ/
kg-body weight/day, according to 2006 WHO TEFs.
Furthermore, 11 people were found to exceed the tolerable
daily intake (TDI) of 4 pg-TEQ/kg-body weight/day
according to 2006 WHO TEFs.
The follow-up survey conducted from 2002e2007 on the
participants who also participated in the previous survey
reported that blood dioxin concentrations remained at
nearly the same levels.Japan Environment and Children’s Study
Even though a lot of evidence on environmental pollution
caused by many chemical substances, such as persistent
organic pollutants (POPs), has been accumulated, health
effects due to chemical exposure, especially in children,
still remain uncertain. That’s why in January 2011 the
Ministry of the Environment of Japan launched the Japan
Environment and Children’s Study (JECS) to clarify the
relationship between chemical exposure during the fetal
and infant stages and adverse health effects in children.
This study is based on 6-year preparation procedures by the
Ministry of the Environment of Japan [14]. Details can be
found on the JECS website [14]. One hundred thousand
mother-child pairs will be recruited over a period of 3 years
from designated study areas. Follow-up examinations will
be carried out for 13 years after pregnancy (so-called birth
cohort study). This project will be implemented by the
National Center at the National Institute for Environmental
Studies and supported by the Medical Support Center at the
National Center for Child Health and Development. Fieldoperations will be performed at 15 designated regional
centers nationwide.
Comments
It should be noted that research in the field of food and
drug safety assessment/management is performed under
the circumstances of limited scientific evidence. Tragic
episodes, such as Yusho (occurred in Japan in 1968) and
Yucheng (occurred in Taiwan in 1979), should be carefully
observed, followed, and analyzed in order to develop
a healthy society and provide better healthcare to the
victims.
Finally, we should remember the saying by Confucius:
“When you know a thing, to hold that you know it; and
when you do not know a thing, to allow that you do not
know it; this is knowledge.”
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